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Abstract
Background: Presence of corneal cystine crystals is the main ocular manifestation of cystinosis, although
controversial findings concerning the corneal layer with the highest density have been reported. The aim of this
study was the analysis of the characteristics of crystal arrangement in different corneal layers and the assessment of
corneal morphological changes with age.
Methods: A cross sectional study was carried out in three children and three adults who had nephropathic
cystinosis and corneal cystine depositions. All patients underwent a comprehensive ophthalmological examination
including best corrected distance visual acuity, slit-lamp examination, in vivo confocal microscopy and anterior
segment optical coherence tomography. An evaluation of the depth of crystal deposits and crystal density in
different corneal layers was also performed. Due to the low number of subjects no statistical comparison was
performed.
Results: Anterior segment optical coherence tomography images revealed deposition of hyperreflective crystals
from limbus to limbus in each patient. Crystals appeared as randomly oriented hyperreflective, elongated structures
on in vivo confocal microscopy images in all corneal layers except the endothelium. In children the deposits
occurred predominantly in the anterior stroma, while in adults, the crystals were mostly localized in the posterior
corneal stroma with the depth of crystal deposition showing an increasing tendency with age (mean depth of
crystal density was 353.17 ± 49.23 μm in children and it was 555.75 ± 25.27 μm in adults). Mean crystal density of the
epithelium was 1.47 ± 1.17 (median: 1.5; interquartile range: 0.3–2.4). Mean crystal density of the anterior and
posterior stroma of children and adults was 3.37 ± 0.34 (median: 3.4; interquartile range: 3.25–3.55) vs. 1.23 ± 0.23
(median: 1.2; interquartile range: 1.05–1.35) and 0.76 ± 0.49 (median: 0.7; interquartile range: 0.4–1.15) vs. 3.63 ± 0.29
(median: 3.7; interquartile range: 3.45–3.8), respectively. Endothelium had intact structure in all cases. Some
hexagonal crystals were observed in two subjects.
Conclusions: In vivo confocal microscopy and anterior segment optical coherence tomography confirmed an age-
related pattern of crystal deposition. In children, crystals tend to locate anteriorly, while in adults, deposits are found
posteriorly in corneal stroma.
Keywords: Cornea, Nephropathic cystinosis, Corneal crystals, In vivo confocal microscopy, Anterior segment optical
coherence tomography
© The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
* Correspondence: csorba.anita@semmelweis-univ.hu
1Department of Ophthalmology, Semmelweis University, Budapest, Hungary
Full list of author information is available at the end of the article
Csorba et al. BMC Ophthalmology           (2020) 20:73 
https://doi.org/10.1186/s12886-020-01336-w
Background
Cystinosis is a rare autosomal recessive storage disease,
which results from mutation in the CTNS gene located
at 17p13.2 [1] with an estimated incidence reported to
be 1 in 100,000–200,000 live births [1]. CTNS encodes
cystinosin, a lysosomal transmembrane protein trans-
porter, which is responsible for transporting cystine
amino acid out of the lysosome. Due to the mutation,
cystine accumulates in lysosomes and forms insoluble
crystals. The crystal deposits appear in various tissues
causing functional impairment of the organs [2], espe-
cially of the kidneys and of the eyes [3, 4].
Nephropathic or infantile cystinosis is the most fre-
quent (95% of cases) and the most severe phenotype of
the disease [5]. It is characterized by renal Fanconi syn-
drome, which begins in infancy, usually from 6 to 12
months of age [3]. Destruction of kidney tubules leads to
end-stage renal failure and usually requires renal trans-
plantation in the first decade of life [2]. The availability
of kidney transplantation since the 1960s prolongs life
expectancy [3]; however, after transplantation there is an
ongoing crystallization and therefore extrarenal manifes-
tations such as ophthalmic complications are more
prominent [3, 6].
Cystinosis affects all ocular structures. The most fre-
quently described ocular manifestation is cystine crystal
deposition in the cornea [7], but the exact mechanisms
of crystal formation are not fully understood yet. In the
infantile form the deposits can be seen from the age of
16 months onwards by slit-lamp biomicroscopy [8], and
the number of deposits increases with age [9]. Interest-
ingly, different studies have shown contradictory results
as to which corneal layer is most affected by crystal de-
position [2, 5, 10, 11].
In vivo confocal microscopy (IVCM) is the best im-
aging technique to represent corneal cystine crystals
in vivo [2, 3, 7, 9, 10, 12, 13]. IVCM enables quantifica-
tion and identification of the deposits at the cellular level
and thus this imaging modality is the gold standard for
ophthalmological follow-up of patients with cystinosis
[1].
Anterior segment optical coherence tomography (AS-
OCT) is a relatively novel imaging technique for cross-
sectional analysis of the anterior structures of the eye in-
cluding the cornea. It does not require any contact and
hence it is preferable in patients with low compliance
for any corneal contact examinations, such as IVCM [7].
Although this examination is faster and less inconveni-
ent for the patients, very few studies are available using
AS-OCT for corneal analysis of patients with cystinosis
[7, 9].
The literature differs as to which corneal layer has the
highest crystal density, and the reason for this difference
is unknown. The aim of this study was to investigate
whether the age of patients with cystinosis has any influ-
ence on corneal crystal morphology and arrangement. In
the present work we describe the characteristics of cor-
neal crystals in patients of different ages with nephro-
pathic cystinosis using IVCM and AS-OCT.
Methods
A cross sectional study was carried out at the Depart-
ment of Ophthalmology, Semmelweis University with
the approval of the Semmelweis University Regional and
Institutional Committee of Sciences and Research Ethics.
Each participant received information about the study,
written consent was obtained from the patients or the
parents or legal guardians of subjects under the age of
18 years. All subjects were treated in accordance with
the tenets of the Declaration of Helsinki.
Six patients (4 males, 2 females, age 8 years to 36
years) with nephropathic cystinosis were enrolled in our
study. Three children (2 boys and 1 girl, aged 8, 12 and
15 years) and three adults (2 men and 1 woman, aged
24, 26 and 36 years) were included. Patients were en-
rolled if they had previously diagnosed nephropathic
cystinosis and if corneal crystals were observed in their
eyes by slit-lamp examination. All subjects were receiv-
ing oral cysteamine bitartrate (Cystagon®, Orphan Eur-
ope S.A.R.L., Puteaux, France) and were on a topical
therapy with 0.1% cysteamine hydrochloride (obtained
from the University Pharmacy Department of Pharmacy
Administration, Budapest, Hungary) applied once to four
times daily.
First, patients underwent a comprehensive ophthalmo-
logical examination including best corrected distance visual
acuity (BCDVA, measured with Snellen chart and con-
verted to logMAR values) assessment followed by slit-lamp
biomicroscopy. AS-OCT examinations were performed on
all eyes using AngioVue OCT (RTVue-XR, Avanti, Opto-
vue, Fremont, CA, USA), which provides 12 × 9mm scans
with an axial resolution of 5 μm and a transversal resolution
of 15 μm. The depth of crystal deposition (DCD) was mea-
sured with the caliper function from the anterior corneal
surface to the deepest point of crystal deposition in the cen-
ter of the cornea. Central corneal thickness (CCT) values
were measured automatically by the software and derived
from the pachymetry map. Finally, IVCM analysis of the
central cornea was performed with the Rostock Cornea
Module of Heidelberg Retina Tomograph-III (Heidelberg
Engineering GmbH, Heidelberg, Germany). Before the
examination one drop 0.4% oxybuprocaine (Benoxi®, Uni-
med Pharma, Bratislava, Slovakia) and one drop of artificial
tear gel (0.2% carbomer, Vidisic®, Chem.-pharm. Fabrik
GmbH, Brunsbütteler, Berlin, Germany, Bausch&Lomb)
were instilled locally in the lower cul-de-sac. The micro-
scope lens was covered by a sterile polymethyl methacrylate
cap (TomoCap®, Heidelberg Engineering GmbH). Images
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were taken of each layer in the central cornea from the epi-
thelium to the endothelium using the instrument’s section
mode. IVCM images represent an en face section of the
cornea with a resolution of 384 × 384 pixels covering a
0.4 × 0.4mm2 area. No corneal complications developed
due to the IVCM examination. All IVCM measurements
were recorded, and images were analyzed by the same
examiner (A.Cs.). The crystal density (CD) was quantified
using CD scoring system as previously published [9]. CD
was evaluated in different corneal layers, i.e. the epithelium,
anterior stroma, posterior stroma and endothelium (graded
from 0 to 4: 0, no crystal; 1, < 25%; 2, 25 to 50%; 3, 50 to
75%; 4, > 75%; the percentage was based on the quotient of
the area affected by crystal deposition and the whole field
of each image). The CD of one corneal layer represented
the mean of 5 pictures analyzed. The values of DCD and
CD for patients of different ages were evaluated. No statis-
tical analysis was performed due to the low number of
patients.
Results
A total of 12 eyes of 6 patients with nephropathic cysti-
nosis were examined in our study. All subjects were in
good general health. The three adults and the oldest
child underwent renal transplantation previously. The
involved patients under 18 years old were siblings. The
majority of subjects had normal visual acuity. Slit-lamp
biomicroscopy revealed diffuse crystal deposition
throughout the entire cornea in all patients. In Patient
1–5 there was not detectable any sign of corneal oedema
or scarring. As a late-onset complication of corneal in-
volvement of nephropathic cystinosis Patient 6 had cor-
neal scarring on both of her eyes and a plaque-like band
keratopathy on the left cornea, which explains her low
visual acuity and high corneal thickness (674 μm). The
mean CCT in the remained 11 eyes of 6 examined
patients was 582.45 ± 25.91 μm. Clinical characteristics
of the patients are shown in Table 1.
AS-OCT images revealed deposition of hyperreflective
crystals from limbus to limbus in each patient. Patient 6
was excluded from DCD measurement because due to
the corneal scarring appearing as a hyperreflective area
on AS-OCT scans, exact distinguishment of hyperreflec-
tive crystals from scarred areas was not possible. The
scans showed that with increasing age the crystal de-
posits are located deeper (Fig. 1a–e). In younger children
only the anterior stroma is affected (Fig. 1a, b), whereas
in the oldest child (15 years old) the majority of the de-
posits affects the anterior and the middle stroma as well
(Fig. 1c). In these patients, crystals in the posterior parts
were not observed. In adults, the crystals are mostly lo-
calized in the posterior two-third of the corneal stroma
(Fig. 1d,e).
The mean DCD was 353.17 ± 49.23 μm in children and
it was 555.75 ± 25.27 μm in adults. Figure 2 shows the
DCD values plotted against the age of the subjects. On
Table 1 Clinical characteristics. BCDVA = best corrected distance
visual acuity (logMAR)
Patient Age (years) Gender Renal transplantation Eye BCDVA
1 8 male no OD 0.0
OS 0.0
2 12 male no OD 0.0
OS 0.0
3 15 female yes OD 0.0
OS 0.0
4 24 male yes OD 0.0
OS 0.0
5 26 male yes OD 0.0
OS 0.0
6 36 female yes OD 1.0
OS 1.0
Fig. 1 Anterior segment optical coherence tomography (AS-OCT)
scans of the cornea in nephropathic cystinosis in ascending order
with age. (a–c) In children, the anterior stroma is predominantly
involved in crystal deposition. In Patient 3 (C) the crystal location is
deeper, but the posterior stroma is still not affected. (d–e) On the
contrary, in adults the crystals are mostly located in the
posterior stroma
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the graph, the two eyes are showing similar values, and
age-related tendency of crystal deposition can be seen.
On IVCM images the crystals appeared as hyperreflec-
tive, sharply demarcated, elongated structures in differ-
ent size and shape. In each layer, the crystals were
oriented randomly without any differentiation and could
be observed throughout the entire the cornea except the
endothelium. Within the epithelial layer short and thin
deposits were seen extracellularly in nine eyes of five pa-
tients. The mean CD of the epithelium was 1.47 ± 1.17
(median: 1.5; interquartile range [IQR]: 0.3–2.4). All ex-
amined patients had crystals in the full thickness of cor-
neal stroma. In our three children, narrow and needle-
shaped deposits were found predominantly in the anter-
ior stroma. On these images keratocytes were not de-
tected (Fig. 3a). The mean CD in the anterior stroma of
children was 3.37 ± 0.34 (median: 3.4; IQR: 3.25–3.55).
In adults thick and long crystals were aggregated in the
anterior stroma and they were surrounded by homoge-
neous, acellular hyporeflective areas (Fig. 3c). The mean
CD in the anterior stroma of adults was 1.23 ± 0.23 (me-
dian: 1.2; IQR: 1.05–1.35). In the anterior stroma CD
was found to be greater in younger patients than in
older ones (Fig. 4). In the posterior corneal stroma of
children crystals were narrower, keratocyte nuclei were
seen clearly, and normal stromal structure was detected
with a mean CD of 0.76 ± 0.49 (median: 0.7; IQR: 0.4–
1.15) (Fig. 3b). The cell borders of keratocytes were not
visible; therefore, it could not be determined whether
the crystals were located intra- or extracellularly. In
adults, the highest crystal density was found in the pos-
terior stroma with a mean CD of 3.63 ± 0.29 (median:
3.7; IQR: 3.45–3.8). Other cells could not be detected in
this layer, either (Fig. 3d) (Fig. 4). The endothelial cell
layer had an intact structure in all cases. Data of DCD
and CD values in different corneal layers are shown in
Table 2.
Fig. 2 Depth of crystal deposition (DCD) measured on anterior segment optical coherence tomography images. DCD values show an increasing
tendency with age. In all patients available for the measurement the DCD values were symmetrical in both eyes that is observable on the
distribution of the plot
Fig. 3 In vivo confocal microscopy (IVCM) images showing different
stromal arrangement of the deposits. (a) In children, many deposits
are in the anterior stroma. (b) The posterior stroma is intact in
children: few crystals and many keratocytes are visible. (c) On the
contrary, few crystals are aggregated in the anterior stroma of
adults, whereas (d) their posterior stroma has high crystal density
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According to the IVCM recordings, most of the corneal
crystals were oblong and needle-shaped. Interestingly,
hexagonal crystals were also detectable in two patients. In
Patient 1 (8 years old) only a few of these crystals were vis-
ible in the anterior stroma (Fig. 5a). In Patient 5 (26 years
old), several hexagonal crystals were detected in both the
anterior and posterior stroma (Fig. 5b).
Discussion
To the best of our knowledge, this is the first study to
investigate the properties of crystal localization in cysti-
nosis in different age groups, by employing IVCM and
AS-OCT imaging. In our report 12 eyes of 6 patients
with nephropathic cystinosis were assessed to describe
the appearance of corneal cysteine crystals, which is a
characteristic symptom of this disorder [3]. Epithelial in-
volvement was observed in 5 out of 6 patients, in agree-
ment with the results of several previous studies [2, 7, 9,
14]. Interestingly, the endothelium was spared in all
cases in this series, although some previous data indicate
that endothelial involvement may also occur [11, 15].
In the literature there are contradictory data on the stro-
mal pattern of corneal crystal deposition. Most of the
studies describe that the majority of the crystals is located
in the anterior or in the posterior stroma [9, 10], while
some case reports describe the main involvement of the
middle layer [2, 5]. Previous histopathological and clinical
studies confirmed that crystal deposition begins at the an-
terior and peripheral part of the cornea and spreads pos-
teriorly and centrally with aging [11, 16, 17]. Indeed, our
Fig. 4 Crystal density (CD) of anterior and posterior stroma. Semiquantitative analysis of deposits showed higher density in the anterior stroma in
children and higher density in the posterior stroma in adults. ▲ CD in the anterior stroma; ○ CD in the posterior stroma
Table 2 Central corneal thickness (CCT) in μm, depth of crystal deposition (DCD) in μm and crystal density (CD) values in the study
subjects. The CD values were derived from five measurements in the given area
Patient Eye CCT DCD CD
Epithelium Anterior stroma Posterior stroma Endothelium
1 OD 613 329 1.6 3.4 0.4 0.0
OS 627 291 1.2 2.8 0.2 0.0
2 OD 611 317 1.4 3.2 1.0 0.0
OS 583 369 2.4 3.8 0.4 0.0
3 OD 582 392 3.2 3.4 1.2 0.0
OS 550 421 2.4 3.6 1.4 0.0
4 OD 564 552 0.0 1.2 4.0 0.0
OS 554 585 0.4 1.0 3.8 0.0
5 OD 555 562 2.0 1.4 3.6 0.0
OS 587 524 3.0 1.6 3.8 0.0
6 OD 581 – 0.0 1.0 3.2 0.0
OS 674 – 0.0 1.2 3.4 0.0
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results were in accordance with these previous reports: in
our three children, crystal deposition mostly affected the
anterior stroma, while in adults, the posterior stroma had
the highest crystal density. We also found that despite this
localization trend the entire corneal stroma was affected
in all ages. According to our data, crystals appear through-
out the whole thickness of the cornea with older age. Both
AS-OCT and IVCM showed that accumulation of the
crystal deposits has increasing tendency in the posterior
stroma with aging.
Our results may suggest that the deposition of cystine
crystals is associated with changes in keratocyte popula-
tion. In regions where crystals were deposited, kerato-
cyte dropout was observed. Hence, in children, the
posterior stromal parts had normal keratocytes, whereas
in adults, keratocytes could not be observed at full thick-
ness. In vitro studies reported progressive keratocyte dis-
ruption, keratocyte loss in corneal cystinosis and higher
apoptotic rate in nephropathic cystinotic fibroblasts [18,
19]. These results support our in vivo findings about the
absence of keratocytes in areas affected by crystal
deposits.
Moreover, hexagonal crystals were found in two pa-
tients located in the stroma. According to histopatho-
logical and IVCM studies, corneal crystals are usually
needle-shaped [10, 11, 20, 21], while they have hex-
agonal or polygonal configurations in the other parts of
the body [22]. Dixon et al. emphasized the role of the
stromal collagen in needle-shaped crystallization [23].
According to their results, due to the charge-charge in-
teractions between the anionic collagen fibrills and cat-
ionic cystine, cystine amino acid is bound to the surface
of collagen. The tightly located collagen lamellae inhibit
the three dimensional growth, hence the polygonal
forming of cysteine crystals [23]. Presentation of hex-
agonal deposits in our patients suggests that the regular,
tightly packed structure of the collagen lamellae in the
cornea may change, thus, the growth of the crystals may
occur not only parallel, but in vector direction of the
collagen fibers, as well.
In nephropathic cystinosis several age-related corneal
complications have been reported i.e. band keratopathy,
corneal neovascularization, filamentary keratopathy and
corneal scarring [24, 25], but the exact cause of these
complications remained unclear. So far, we are not
aware of any association between the changes in stromal
microarchitecture and the risk of developing any late-
onset corneal complication in nephropathic cystinosis.
Future prospective studies are required to elucidate the
significance of crystal location and stromal alterations in
the development of late-onset complications.
We performed AS-OCT examinations in all our pa-
tients. Due to the non-invasive nature of AS-OCT,
examination can be performed easily even in very young
patients (see the 8-year-old subject in our study). On
cross-sectional scans it is easy to determine which part
of the cornea has the highest density of crystals; how-
ever, epithelial and endothelial involvement could not be
determined by this imaging method due to its lower
resolution. Moreover, corneal scarring makes impossible
exact DCD value measuring, because crystals are not vis-
ible in the area of the scar.
Our study suggests that due to its higher magnification
(approximately 800×) and higher resolution (1–2 μm/
pixel), IVCM could be more advantageous than AS-
OCT for the assessment of corneal deposits in cystinosis.
First, with this method we were able to evaluate the in-
volvement of epithelium and endothelium. Second, the
deposits could be observed in regions of corneal scarring
as well, and their amount could be determined. Finally,
we found deposits throughout the full corneal thickness
in all examined patients, even in those patients who had
Fig. 5 Hexagonal crystals. (a) One hexagonal crystal is visible on the IVCM image of a child. (b) Some hexagonal crystals in adult
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only anterior corneal involvement according to DCD
values on AS-OCT images. Although IVCM is able to
assess corneal involvement very precisely, this technique
cannot be performed on patients who have difficulties
with contact examination. The severity of corneal in-
volvement has been assessed in previous studies using
the Gahl-score, based on a collection of slit-lamp photo-
graphs of corneas containing cystine crystals at different
densities [8]. In 2009, Labbé et al. published a new
IVCM scoring system which provides more accurate
evaluation of crystal density than the aforementioned
Gahl-score [9]. Another advantage of the IVCM scoring
system is that it enables the comparative evaluation of
crystal density in different layers of the cornea.
Precise location and depth of crystals within corneal
layers can only be evaluated by IVCM and AS-OCT.
However, in most of clinical studies investigating the ef-
fects of topical cysteamine hydrochlorid (CH), crystal
density was evaluated according to slit-lamp photog-
raphy [8, 14, 26–29]. No study is currently available
about life-long effects of topical CH drops on exact ar-
rangement of deposits and about its impact on age-
dependent changes. Diffusion of hydrophilic CH through
the lipophilic epithelium is low [30]. Due to short cor-
neal contact time, dose regimen is frequent up to 12
times per day and the aqueous solution of CH is un-
stable at room temperature [31]. These factors impose a
significant burden on patients and may lead to poor ad-
herence [31]. Efficacy of 0.1% CH drops in reduction of
crystal density is low even in anterior stroma [12]. All
these limitations make it less likely that topical CH
would have profound impact on the arrangement of de-
posits at full depth of the cornea. Recently, a new gel so-
lution of CH has been developed. High viscosity of the
gel form prolongs corneal contact time, which contrib-
utes to deeper penetration and less frequent administra-
tion (3–5 times per day) [12, 13].
In this manuscript, we analyzed the properties of cyst-
ine crystal location and the morphology of corneal struc-
ture in different ages. The rare occurrence of the disease
could not make it possible to involve more subjects, so
the potential limitation in our study could be the low
number of cases. However, only case reports [2, 5, 10]
and one research article [9] with low number of subjects
can be found using IVCM and/or AS-OCT in which
crystal localization is also reported. Thus, we believe tak-
ing into consideration this limitation our study provides
important results and shows clearly the inherent ten-
dency of linearity between the age and stromal density
of the deposited crystals. The other main limitation of
our study is the lack of statistical evaluation. We have
attempted to divide the patients into two subgroups to
represent the differences between younger and older
age, however, we could not statistically evaluate the
average values of these two groups because of the small
number of patients. The present study was not primarily
concerned with the distinction between children and
adults in terms of deposition of crystals, but showed the
relationship between localization of the crystals and the
age of the patients. Due to the rarity of cystinosis,
recruiting a large cohort of these patient in different ages
is challenging, but it could provide precise statistical
evaluation which may confirm our results.
Conclusion
In our study, we provided new data about corneal
microarchitecture in nephropathic cystinosis. Both AS-
OCT and IVCM are seemingly useful methods to assess
the cystine crystals in the cornea in cystinosis and desir-
able to be used for detection of morphological features
of cystine crystals and corneal alterations. Our results
suggest that there is a tendency of age-related redistribu-
tion of crystal deposits in the posterior stroma, while
loss of keratocytes can be observed. Some hexagonal
crystals may occur in the stroma, but the exact cellular
mechanism is unknown. These results could be useful to
explore morphological changes of the cornea in nephro-
pathic cystinosis. Nevertheless, further prospective stud-
ies, also with in vitro examinations, are required to
elucidate the process of corneal changes and exact cellu-
lar and molecular pathomechanisms in nephropathic
cystinosis with aging.
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